Notice to stakeholders: Harmonizing fludeoxyglucose (F-18 FDG) product monographs

Health Canada recommends modified wording for the indications and clinical uses of fludeoxyglucose (F-18 FDG) products in their product monographs. The modified wording aims to bring the indications and clinical uses for F-18 FDG up-to-date and harmonize the product monographs in this regard.

Publisher
Health Canada
Resources
2
Catalogue metadata updated
2021-12-29

Data overview

Formats
HTML
File languages
English, French

Official sources and licences

Resources

Related open data